We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Meet the Editors

Addiction | Annals of Medicine

Annals of Medicine is excited to share the list of associates joining the Addiction section Editorial Team. With direction from the Section Editor, Khary Rigg, an Aims and Scope has been outlined for the section, providing clarity on the research topics of focus and main objectives.
Continue down the page to learn more.

Section Editor

Khary Rigg, PhD

Department of Mental Health Law and Policy, Louis de la Parte Florida Mental Health Institute, University of South Florida, Tampa, FL, USA

Dr. Rigg is an Associate Professor in the Department of Mental Health Law and Policy at the University of South Florida. He also has appointments in the Department of  Criminology, Department of Sociology, and the Louis de la Parte Florida Mental Health Institute. He is a behavioral health services and policy researcher with over 15 years of experience studying substance use disorders. Dr. Rigg earned his Ph.D. from the University of Miami and completed a postdoctoral fellowship in health services research at the University of Pennsylvania Perelman School of Medicine. His recent research has focused on understanding determinants of opioid misuse and overdose through a racial/ethnic and urban-rural lens.

Associate Editor

Ricky Bluthenthal, PhD

Department of Preventive Medicine, Institute for Prevention Research, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

Dr. Bluthenthal is the Associate Dean for Social Justice and a Professor in the Department of Preventive Medicine and the Institute for Prevention Research at the Keck School of Medicine, University of Southern California. He received his Ph.D. in sociology from the University of California Berkeley. His research has established the effectiveness of syringe service programs, examined the impacts of cannabis legalization, and tested novel interventions to reduce HIV risk among people who inject drugs. 

Associate Editor

Ayana Jordan, MD, PhD

Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA

Dr. Jordan is an Assistant Professor of Psychiatry at the Yale School of Medicine and an attending physician at the Connecticut Mental Health Center. She earned her M.D. and Ph.D. from the Albert Einstein College of Medicine of Yeshiva University and completed an adult psychiatric residency and addiction psychiatry fellowship at Yale University. Her recent research focuses on increasing access to addiction services and improving drug treatment outcomes for minority communities, both nationally and abroad. 

Associate Editor

Hilary L. Surratt, PhD

Department of Behavioral Science, University of Kentucky, Lexington, KY, USA

Dr. Surratt is an Associate Professor in the Department of Behavioral Science at the University of Kentucky College of Medicine. She received a Ph.D. in psychology from the City University of New York and completed a graduate certificate in Latin American Studies from the University of Florida. She has expertise in the areas of illicit and prescription drug misuse, prescription drug diversion and drug-related HIV infection. Her work has included the development and evaluation of behavioral interventions for vulnerable substance using populations in community settings, as well as epidemiologic studies of prescription drug misuse and diversion, including opioid analgesics and antiretroviral medications.

Associate Editor

Hansel Tookes, MD, MPH

Miller School of Medicine, University of Miami, Coral Gables, FL, USA

Dr. Tookes is an Assistant Professor at the University of Miami Miller School of Medicine. He earned his M.D. and MPH from University of Miami and completed his residency at Jackson Memorial Hospital in internal medicine with a focus on HIV primary care. His research is focused on improving health outcomes for people who inject drugs and his work often has a harm reduction and drug policy focus. His most recent research has advanced best practices in the implementation of syringe service programs in urban settings. 

Editorial Board

Sean T. Allen, DrPH

Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA

Kara S. Bagot, MD

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Tyler S. Bartholomew, PhD

Miller School of Medicine, University of Miami, Coral Gables, FL, USA

Paul T. Harrell, PhD

Department of Pediatrics, Eastern Virginia Medical School, Norfolk, VA, USA

Kimberly A. Johnson, PhD

International Consortium of Universities for Drug Demand Reduction, Tampa, FL, USA

Steven L. Proctor, PhD

PRO Health Group, Thriving Mind South Florida, Department of Psychiatry & Behavioral Health, Florida International University, Miami, FL, USA

Danelle Stevens-Watkins, PhD

Center on Drug and Alcohol Research, University of Kentucky, Lexington, KY, USA

Christine Vinci, PhD

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Tamika C. Zapolski, PhD

Department of Psychology, Indiana University-Purdue University Indianapolis, Indianapolis, IN, USA

Aims and Scope

The Addiction section of Annals of Medicine publishes peer-reviewed research and perspectives that advance our understanding of addiction and its consequences. The section is especially interested in publishing clinically relevant articles that can help improve quality of care and outcomes for individuals with problems related to alcohol, illegal and prescription drugs, cannabis, and nicotine. This includes articles that inform how prevention, treatment, and harm reduction interventions are developed and delivered. 

The section's goal is to be a source of timely information for the international community of clinicians and public health professionals working in the substance use field. While studies from all disciplines and service settings will be considered, submissions must have clear relevance for improving healthcare and service provision to persons with addiction. Policy-focused articles that have implications for improving addiction services are also welcome.

Topics covered include:
Addiction Workforce Issues
Adolescent Substance Use
Behavioral and Pharmacological Treatments
Chronic Pain and Addiction
Co-Occurring Infectious Diseases and Psychiatric Disorders
Harm Reduction
Integration of Primary Care and Addiction Services
Methodological Issues in Addiction Research
Neonatal Abstinence Syndrome
Older Adult Substance Use
Overdose Prevention/Treatment
Pharmacotherapy
Primary Prevention and Early Intervention
Racial Equity in Addiction Treatment
Recovery and Self-Help Groups
Social Determinants of Addiction
Stigma
Substance Use Epidemiology
Treatment of Special Populations

About Annals of Medicine

Fully open access, general medical journal publishing articles under a CC BY license, allowing maximum sharing and reuse of articles to our international readership;

Publishing all scientifically valid research, including reporting of negative and null data, from translational to clinical research in all disciplines and therapy areas;

Led by an international editorial team of subject experts who ensure a constructive and rigorous peer review process;

Your research is promoted via a tailored, multi-channel approach to maximize visibility, readership and impact.

Prepare Submission          Submit Manuscript

Q1 Rank
Two-Year Impact Factor 3.243
Five-Year Impact Factor 3.840
-Journal Citation Reports®

 

MEDLINE® Indexed

 

CiteScore 5.70
- Scopus®